Clinical Trial Update: Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer [Phase 4]

View source ↗

Summary

Clinical trial update on using irinotecan plus thalidomide in second-line advanced gastric cancer (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Thalidomide (thalidomide)

Snippet

Sponsor: Wang Jufeng | Conditions: Gastric Cancer | Phase 4 | Status: UNKNOWN